Ketamine

Recent articles

Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read

Explore more from The Transmitter

Research image of an assembloid.

Organoids and assembloids offer a new window into human brain

These sophisticated 3D cultures reveal previously inaccessible stages of human brain development and enable the systematic study of disease genes.

By Sergiu P. Pasca
31 March 2025 | 6 min read

Who funds your basic neuroscience research? Help The Transmitter compile a list of funding sources

We want to hear from you about the sources of funding for your research.

By Claudia López Lloreda
28 March 2025 | 1 min read
University of Puerto Rico building.

The future of neuroscience research at U.S. minority-serving institutions is in danger

Cuts to federally funded programs present an existential crisis for the University of Puerto Rico’s rich neuroscience community and for research at minority-serving institutions everywhere.

By Carmen S. Maldonado-Vlaar
28 March 2025 | 5 min read